Cargando…
Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973953/ https://www.ncbi.nlm.nih.gov/pubmed/24037406 http://dx.doi.org/10.1007/s00253-013-5192-3 |
_version_ | 1782479399958872064 |
---|---|
author | Dragosits, Martin Pflügl, Stefan Kurz, Simone Razzazi-Fazeli, Ebrahim Wilson, Iain B. H. Rendic, Dubravko |
author_facet | Dragosits, Martin Pflügl, Stefan Kurz, Simone Razzazi-Fazeli, Ebrahim Wilson, Iain B. H. Rendic, Dubravko |
author_sort | Dragosits, Martin |
collection | PubMed |
description | Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases to be present in a purified form with clearly defined properties, including precisely determined substrate specificities, low sensitivity to inhibitors, and high efficiency and stability under distinct conditions. In this study, we present the recombinant expression and purification of two previously uncharacterized β-galactosidases from Aspergillus nidulans as well as one β-galactosidase from Aspergillus niger. All enzymes were active toward p-nitrophenyl-β-d-galactopyranoside as substrate and displayed similar temperature and pH optima. The purified recombinant galactosidases digested various complex substrates containing terminal galactose β-1,4 linked to either N-acetylglucosamine or fucose, such as N-glycans derived from bovine fibrin and Caenorhabditis elegans. In our comparative study of the recombinant galactosidases with the commercially available galactosidase from Aspergillus oryzae, all enzymes also displayed various degrees of activity toward complex oligosaccharides containing β-1,3-linked terminal galactose residues. All recombinant enzymes were found to be robust in the presence of various organic solvents, temperature variations, and freeze/thaw cycles and were also tested for their ability to synthesize galactooligosaccharides. Furthermore, the use of fermentors considerably increased the yield of recombinant galactosidases. Taken together, we demonstrate that purified recombinant galactosidases from A. niger and from A. nidulans are suitable for various glycobiological and biotechnological applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-013-5192-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3973953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-39739532014-04-07 Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool Dragosits, Martin Pflügl, Stefan Kurz, Simone Razzazi-Fazeli, Ebrahim Wilson, Iain B. H. Rendic, Dubravko Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases to be present in a purified form with clearly defined properties, including precisely determined substrate specificities, low sensitivity to inhibitors, and high efficiency and stability under distinct conditions. In this study, we present the recombinant expression and purification of two previously uncharacterized β-galactosidases from Aspergillus nidulans as well as one β-galactosidase from Aspergillus niger. All enzymes were active toward p-nitrophenyl-β-d-galactopyranoside as substrate and displayed similar temperature and pH optima. The purified recombinant galactosidases digested various complex substrates containing terminal galactose β-1,4 linked to either N-acetylglucosamine or fucose, such as N-glycans derived from bovine fibrin and Caenorhabditis elegans. In our comparative study of the recombinant galactosidases with the commercially available galactosidase from Aspergillus oryzae, all enzymes also displayed various degrees of activity toward complex oligosaccharides containing β-1,3-linked terminal galactose residues. All recombinant enzymes were found to be robust in the presence of various organic solvents, temperature variations, and freeze/thaw cycles and were also tested for their ability to synthesize galactooligosaccharides. Furthermore, the use of fermentors considerably increased the yield of recombinant galactosidases. Taken together, we demonstrate that purified recombinant galactosidases from A. niger and from A. nidulans are suitable for various glycobiological and biotechnological applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-013-5192-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2013-09-15 2014 /pmc/articles/PMC3973953/ /pubmed/24037406 http://dx.doi.org/10.1007/s00253-013-5192-3 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Biotechnologically Relevant Enzymes and Proteins Dragosits, Martin Pflügl, Stefan Kurz, Simone Razzazi-Fazeli, Ebrahim Wilson, Iain B. H. Rendic, Dubravko Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title | Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title_full | Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title_fullStr | Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title_full_unstemmed | Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title_short | Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
title_sort | recombinant aspergillus β-galactosidases as a robust glycomic and biotechnological tool |
topic | Biotechnologically Relevant Enzymes and Proteins |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973953/ https://www.ncbi.nlm.nih.gov/pubmed/24037406 http://dx.doi.org/10.1007/s00253-013-5192-3 |
work_keys_str_mv | AT dragositsmartin recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool AT pfluglstefan recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool AT kurzsimone recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool AT razzazifazeliebrahim recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool AT wilsoniainbh recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool AT rendicdubravko recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool |